125 related articles for article (PubMed ID: 9666572)
21. Phenytoin-based bivalent ligands: design, synthesis and anticonvulsant activity.
Botros S; Khalil NA; Naguib BH; El-Dash Y
Arch Pharm Res; 2012 Dec; 35(12):2105-16. PubMed ID: 23263804
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticonvulsant activity evaluation of 6-substituted-[1,2,4]triazolo[3,4-a](tetrazolo[5,1-a])phthalazine derivatives.
Bian M; Deng XQ; Gong GH; Wei CX; Quan ZS
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):792-800. PubMed ID: 22994853
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
24. N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.
Geurts M; Poupaert JH; Scriba GK; Lambert DM
J Med Chem; 1998 Jan; 41(1):24-30. PubMed ID: 9438018
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, crystal structure, spectral studies, and catechol oxidase activity of trigonal bipyramidal Cu(II) complexes derived from a tetradentate diamide bisbenzimidazole ligand.
Gupta M; Mathur P; Butcher RJ
Inorg Chem; 2001 Feb; 40(5):878-85. PubMed ID: 11258993
[TBL] [Abstract][Full Text] [Related]
26. Trinuclear Zinc(II) Complexes and Polymeric Cadmium(II) Complexes with the Ligand 2,5-Bis(2-pyridyl)pyrazine: Synthesis, Spectral Analysis, and Single-Crystal and Powder X-ray Analyses.
Neels A; Stoeckli-Evans H
Inorg Chem; 1999 Dec; 38(26):6164-6170. PubMed ID: 11671328
[TBL] [Abstract][Full Text] [Related]
27. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents.
Dong S; Wang T; Hu C; Chen X; Jin Y; Wang Z
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28092111
[TBL] [Abstract][Full Text] [Related]
28. Trinuclear Zn(II) and Cu(II) homo and heterotrimetallic complexes involving D-glucopyranosyl and biscarboxylate bridging ligands. A substrate binding model of xylose isomerases.
Tanase T; Inukai H; Onaka T; Kato M; Yano S; Lippard SJ
Inorg Chem; 2001 Jul; 40(16):3943-53. PubMed ID: 11466052
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II.
Obniska J; Rzepka S; Kamiński K
Bioorg Med Chem; 2012 Aug; 20(15):4872-80. PubMed ID: 22717240
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP
Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles.
Unverferth K; Engel J; Höfgen N; Rostock A; Günther R; Lankau HJ; Menzer M; Rolfs A; Liebscher J; Müller B; Hofmann HJ
J Med Chem; 1998 Jan; 41(1):63-73. PubMed ID: 9438023
[TBL] [Abstract][Full Text] [Related]
33. Structural modifications of the primary amino group of anticonvulsant aryl semicarbazones.
Dimmock JR; Puthucode RN; Lo MS; Quail JW; Yang J; Stables JP
Pharmazie; 1996 Feb; 51(2):83-8. PubMed ID: 8720804
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anticonvulsant activity of 1,3-dihydro-5-phenyl-2H-pyrido[3,2-e]-1,4-diazepin-2-ones.
Fiakpui CY; Knaus EE
Drug Des Discov; 1993; 10(3):173-81. PubMed ID: 8268390
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, and anticonvulsant activity of enaminones. Part 5: investigations on 3-carboalkoxy-2-methyl-2,3-dihydro-1H-phenothizin-4[10H]-one derivatives.
Laws ML; Roberts RR; Nicholson JM; Butcher R; Stables JP; Goodwin AM; Smith CA; Scott KR
Bioorg Med Chem; 1998 Dec; 6(12):2289-99. PubMed ID: 9925291
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
Kamiński K; Rzepka S; Obniska J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
[TBL] [Abstract][Full Text] [Related]
37. Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug.
Isoherranen N; Woodhead JH; White HS; Bialer M
Epilepsia; 2001 Jul; 42(7):831-6. PubMed ID: 11488880
[TBL] [Abstract][Full Text] [Related]
38. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
[TBL] [Abstract][Full Text] [Related]
39. 4-sulphamoylphenyl semicarbazones with anticonvulsant activity.
Yogeeswari P; Sriram D; Pandeya SN; Stables JP
Farmaco; 2004 Aug; 59(8):609-13. PubMed ID: 15262530
[TBL] [Abstract][Full Text] [Related]
40. Metal complexes of the carbonic anhydrase inhibitor methazolamide (Hmacm). Crystal structure of the Zn(macm)2(NH3)2. Anticonvulsant properties of the Cu(macm)2(NH3)3(H2O).
Alzuet G; Casanova J; Ramirez JA; Borrás J; Carugo O
J Inorg Biochem; 1995 Feb; 57(3):219-34. PubMed ID: 7876839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
